FOXD2‐AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma

Long noncoding RNA (lncRNA) FOXD2 adjacent opposite strand RNA 1 (FOXD2‐AS1) has been shown to be dysregulated in several types of human cancer. However, the role of FOXD2‐AS1 in cutaneous melanoma was still unclear. In our study, FOXD2‐AS1 expression has been found to be upregulated in cutaneous melanoma tissue specimens and cell lines compared with that in normal tissue specimens and normal human epidermal melanocyte, respectively. Furthermore, high expression of FOXD2‐AS1 was obviously correlated with deep Breslow thickness, present ulceration, high Clark level and distant metastasis in cutaneous melanoma patients. However, there were no statistical associations between FOXD2‐AS1 expression and cutaneous melanoma patients’ disease‐free survival and overall survival. The results of loss‐of‐function study showed that inhibition of FOXD2‐AS1 suppresses cutaneous melanoma cell proliferation, migration and invasion through regulating phospho‐Akt expression. In conclusion, FOXD2‐AS1 is associated with clinical progression in cutaneous melanoma patients, and functions as oncogenic lncRNA in cutaneous melanoma cells. FOXD2‐AS1 overexpression is observed in cutaneous melanoma tissues and cell lines, and correlated with deep Breslow thickness, present ulceration, high Clark level and distant metastasis in cutaneous melanoma patients. Inhibition of FOXD2‐AS1 suppresses cutaneous melanoma cell proliferation, migration and invasion through regulating phospho‐Akt expression.